Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

The FcRn inhibitor rozanolixizumab reduces human serum IgG concentration: A randomized phase 1 study.

Kiessling P, Lledo-Garcia R, Watanabe S, Langdon G, Tran D, Bari M, Christodoulou L, Jones E, Price G, Smith B, Brennan F, White I, Jolles S.

Sci Transl Med. 2017 Nov 1;9(414). pii: eaan1208. doi: 10.1126/scitranslmed.aan1208. Erratum in: Sci Transl Med. 2017 Dec 6;9(419):.

PMID:
29093180
2.

Racial disparities in cord blood vitamin D levels and its association with small-for-gestational-age infants.

Seto TL, Tabangin ME, Langdon G, Mangeot C, Dawodu A, Steinhoff M, Narendran V.

J Perinatol. 2016 Aug;36(8):623-8. doi: 10.1038/jp.2016.64. Epub 2016 Apr 21.

3.

Vitamin D status and hospitalisation for childhood acute lower respiratory tract infections in Nigeria.

Ahmed P, Babaniyi IB, Yusuf KK, Dodd C, Langdon G, Steinhoff M, Dawodu A.

Paediatr Int Child Health. 2015 May;35(2):151-6. doi: 10.1179/2046905514Y.0000000148. Epub 2014 Oct 21.

PMID:
25331594
4.

Respiratory syncytial virus transplacental antibody transfer and kinetics in mother-infant pairs in Bangladesh.

Chu HY, Steinhoff MC, Magaret A, Zaman K, Roy E, Langdon G, Formica MA, Walsh EE, Englund JA.

J Infect Dis. 2014 Nov 15;210(10):1582-9. doi: 10.1093/infdis/jiu316. Epub 2014 Jun 5.

5.

Pharmacokinetic interactions between lersivirine and zidovudine, tenofovir disoproxil fumarate/emtricitabine and abacavir/lamivudine.

Vourvahis M, Davis J, Langdon G, Layton G, Fang J, Choo HW, Hansson AG, Tawadrous M.

Antivir Ther. 2013;18(6):745-54. doi: 10.3851/IMP2566. Epub 2013 Apr 4.

PMID:
23558061
6.

The effect of lersivirine, a next-generation NNRTI, on the pharmacokinetics of midazolam and oral contraceptives in healthy subjects.

Davis J, Langdon G, Layton G, Chong CL, Ndongo MN, Vourvahis M.

Eur J Clin Pharmacol. 2012 Nov;68(11):1567-72. doi: 10.1007/s00228-012-1287-5. Epub 2012 Apr 22.

PMID:
22527351
7.

The pharmacokinetics of lersivirine (UK-453,061) and HIV-1 protease inhibitor coadministration in healthy subjects.

Vourvahis M, Langdon G, Layton G, Labadie RR, Choo HW, Ndongo MN, Davis J.

J Acquir Immune Defic Syndr. 2012 May 1;60(1):24-32. doi: 10.1097/QAI.0b013e31824c4186.

PMID:
22517413
8.

Pharmacokinetic effects of coadministration of lersivirine with raltegravir or maraviroc in healthy subjects.

Vourvahis M, Langdon G, Labadie RR, Layton G, Ndongo MN, Banerjee S, Davis J.

Antimicrob Agents Chemother. 2012 Feb;56(2):887-92. doi: 10.1128/AAC.00572-11. Epub 2011 Nov 28.

9.

Effects of ketoconazole and valproic acid on the pharmacokinetics of the next generation NNRTI, lersivirine (UK-453,061), in healthy adult subjects.

Langdon G, Davis J, Layton G, Chong CL, Weissgerber G, Vourvahis M.

Br J Clin Pharmacol. 2012 May;73(5):768-75. doi: 10.1111/j.1365-2125.2011.04136.x.

10.

The use of beat-to-beat electrocardiogram analysis to distinguish QT/QTc interval changes caused by moxifloxacin from those caused by vardenafil.

Fossa AA, Langdon G, Couderc JP, Zhou M, Darpo B, Wilson F, Wallis R, Davis JD.

Clin Pharmacol Ther. 2011 Sep;90(3):449-54. doi: 10.1038/clpt.2011.139. Epub 2011 Aug 3.

PMID:
21814193
11.

Variability in the population pharmacokinetics of isoniazid in South African tuberculosis patients.

Wilkins JJ, Langdon G, McIlleron H, Pillai G, Smith PJ, Simonsson US.

Br J Clin Pharmacol. 2011 Jul;72(1):51-62. doi: 10.1111/j.1365-2125.2011.03940.x.

12.

Safety and tolerability of lersivirine, a nonnucleoside reverse transcriptase inhibitor, during a 28-day, randomized, placebo-controlled, Phase I clinical study in healthy male volunteers.

Davis J, Hackman F, Ndongo MN, Choo H, Lewis D, Tawadrous M, Goodrich J, Langdon G.

Clin Ther. 2010 Oct;32(11):1889-95. doi: 10.1016/j.clinthera.2010.10.007.

PMID:
21095483
13.

Translational pharmacokinetic-pharmacodynamic modelling; application to cardiovascular safety data for PF-00821385, a novel HIV agent.

Langdon G, Davis JD, McFadyen LM, Dewhurst M, Brunton NS, Rawal JK, Van der Graaf PH, Benson N.

Br J Clin Pharmacol. 2010 Apr;69(4):336-45. doi: 10.1111/j.1365-2125.2009.03594.x.

14.

Seroprevalence of cysticercosis in children and young adults living in a helminth endemic community in leyte, the Philippines.

Xu JM, Acosta LP, Hou M, Manalo DL, Jiz M, Jarilla B, Pablo AO, Ovleda RM, Langdon G, McGarvey ST, Kurtis JD, Friedman JF, Wu HW.

J Trop Med. 2010;2010:603174. doi: 10.1155/2010/603174. Epub 2010 Mar 29.

15.

Immunoglobulin E (IgE) responses to paramyosin predict resistance to reinfection with Schistosoma japonicum and are attenuated by IgG4.

Jiz M, Friedman JF, Leenstra T, Jarilla B, Pablo A, Langdon G, Pond-Tor S, Wu HW, Manalo D, Olveda R, Acosta L, Kurtis JD.

Infect Immun. 2009 May;77(5):2051-8. doi: 10.1128/IAI.00012-09. Epub 2009 Mar 9.

16.

Population pharmacokinetics of rifampin in pulmonary tuberculosis patients, including a semimechanistic model to describe variable absorption.

Wilkins JJ, Savic RM, Karlsson MO, Langdon G, McIlleron H, Pillai G, Smith PJ, Simonsson US.

Antimicrob Agents Chemother. 2008 Jun;52(6):2138-48. doi: 10.1128/AAC.00461-07. Epub 2008 Apr 7.

17.

Linking preclinical and clinical whole-body physiologically based pharmacokinetic models with prior distributions in NONMEM.

Langdon G, Gueorguieva I, Aarons L, Karlsson M.

Eur J Clin Pharmacol. 2007 May;63(5):485-98. Epub 2007 Mar 8.

PMID:
17345074
18.

Th2 cytokines are associated with persistent hepatic fibrosis in human Schistosoma japonicum infection.

Coutinho HM, Acosta LP, Wu HW, McGarvey ST, Su L, Langdon GC, Jiz MA, Jarilla B, Olveda RM, Friedman JF, Kurtis JD.

J Infect Dis. 2007 Jan 15;195(2):288-95. Epub 2006 Dec 13.

PMID:
17191174
19.

Pro-inflammatory cytokines and C-reactive protein are associated with undernutrition in the context of Schistosoma japonicum infection.

Coutinho HM, Leenstra T, Acosta LP, Su L, Jarilla B, Jiz MA, Langdon GC, Olveda RM, McGarvey ST, Kurtis JD, Friedman JF.

Am J Trop Med Hyg. 2006 Oct;75(4):720-6.

PMID:
17038701
20.

Schistosoma japonicum reinfection after praziquantel treatment causes anemia associated with inflammation.

Leenstra T, Coutinho HM, Acosta LP, Langdon GC, Su L, Olveda RM, McGarvey ST, Kurtis JD, Friedman JF.

Infect Immun. 2006 Nov;74(11):6398-407. Epub 2006 Aug 21.

21.

Oral trimethoprim-sulphamethoxazole levels in stable HIV-infected children.

Zar HJ, Langdon G, Apolles P, Eley B, Hussey G, Smith P.

S Afr Med J. 2006 Jul;96(7):627-9.

22.

Pubertal development predicts resistance to infection and reinfection with Schistosoma japonicum.

Kurtis JD, Friedman JF, Leenstra T, Langdon GC, Wu HW, Manalo DL, Su L, Jiz M, Jarilla B, Pablo AO, McGarvey ST, Olveda RM, Acosta LP.

Clin Infect Dis. 2006 Jun 15;42(12):1692-8. Epub 2006 May 12.

PMID:
16705573
23.

Variability in the population pharmacokinetics of pyrazinamide in South African tuberculosis patients.

Wilkins JJ, Langdon G, McIlleron H, Pillai GC, Smith PJ, Simonsson US.

Eur J Clin Pharmacol. 2006 Sep;62(9):727-35. Epub 2006 May 10. Erratum in: Eur J Clin Pharmacol. 2006 Sep;62(9):779.

PMID:
16685561
24.

Schistosomiasis japonica, anemia, and iron status in children, adolescents, and young adults in Leyte, Philippines 1.

Leenstra T, Acosta LP, Langdon GC, Manalo DL, Su L, Olveda RM, McGarvey ST, Kurtis JD, Friedman JF.

Am J Clin Nutr. 2006 Feb;83(2):371-9.

PMID:
16469997
25.

T-helper-2 cytokine responses to Sj97 predict resistance to reinfection with Schistosoma japonicum.

Leenstra T, Acosta LP, Wu HW, Langdon GC, Solomon JS, Manalo DL, Su L, Jiz M, Jarilla B, Pablo AO, McGarvey ST, Olveda RM, Friedman JF, Kurtis JD.

Infect Immun. 2006 Jan;74(1):370-81.

26.

Now there is a Roth IRA in everyone's future.

Langdon G.

Del Med J. 2005 Nov;77(11):463-4. No abstract available.

PMID:
16353451
27.

Monitoring the ingestion of anti-tuberculosis drugs by simple non-invasive methods.

Sirgel FA, Maritz JS, Venter A, Langdon G, Smith PJ, Donald PR.

Int J Pharm. 2006 Jan 13;307(2):182-7. Epub 2005 Nov 21.

PMID:
16303269
28.

Population pharmacokinetics of rifapentine and its primary desacetyl metabolite in South African tuberculosis patients.

Langdon G, Wilkins J, McFadyen L, McIlleron H, Smith P, Simonsson US.

Antimicrob Agents Chemother. 2005 Nov;49(11):4429-36.

29.

Nutritional status and serum cytokine profiles in children, adolescents, and young adults with Schistosoma japonicum-associated hepatic fibrosis, in Leyte, Philippines.

Coutinho HM, McGarvey ST, Acosta LP, Manalo DL, Langdon GC, Leenstra T, Kanzaria HK, Solomon J, Wu H, Olveda RM, Kurtis JD, Friedman JF.

J Infect Dis. 2005 Aug 1;192(3):528-36. Epub 2005 Jun 30.

PMID:
15995969
30.

Helminth infection and cognitive impairment among Filipino children.

Ezeamama AE, Friedman JF, Acosta LP, Bellinger DC, Langdon GC, Manalo DL, Olveda RM, Kurtis JD, McGarvey ST.

Am J Trop Med Hyg. 2005 May;72(5):540-548.

31.

Relationship between Schistosoma japonicum and nutritional status among children and young adults in Leyte, the Philippines.

Friedman JF, Kanzaria HK, Acosta LP, Langdon GC, Manalo DL, Wu H, Olveda RM, McGarvey ST, Kurtis JD.

Am J Trop Med Hyg. 2005 May;72(5):527-33. Erratum in: Am J Trop Med Hyg. 2005 Jul;73(1):230.

PMID:
15891125
32.

Schistosoma japonicum and occult blood loss in endemic villages in Leyte, the Philippines.

Kanzaria HK, Acosta LP, Langdon GC, Manalo DL, Olveda RM, McGarvey ST, Kurtis JD, Friedman JF.

Am J Trop Med Hyg. 2005 Feb;72(2):115-8.

PMID:
15741543
33.

Numbers can lie except when they are zero.

Langdon G.

Del Med J. 2004 Oct;76(10):373-5. No abstract available.

PMID:
15568395
34.

Consecutive-dose pharmacokinetics of rifapentine in patients diagnosed with pulmonary tuberculosis.

Langdon G, Wilkins JJ, Smith PJ, McIlleron H.

Int J Tuberc Lung Dis. 2004 Jul;8(7):862-7.

PMID:
15260278
35.

Structure of a helically extended SH3 domain of the T cell adapter protein ADAP.

Heuer K, Kofler M, Langdon G, Thiemke K, Freund C.

Structure. 2004 Apr;12(4):603-10.

36.

Anabaena apoflavodoxin hydrogen exchange: on the stable exchange core of the alpha/beta(21345) flavodoxin-like family.

Langdon GM, Jiménez MA, Genzor CG, Maldonado S, Sancho J, Rico M.

Proteins. 2001 Jun 1;43(4):476-88.

PMID:
11340663
37.

Bacteriocin AS-48, a microbial cyclic polypeptide structurally and functionally related to mammalian NK-lysin.

González C, Langdon GM, Bruix M, Gálvez A, Valdivia E, Maqueda M, Rico M.

Proc Natl Acad Sci U S A. 2000 Oct 10;97(21):11221-6.

38.

Sequence-specific 1H assignment and secondary structure of the bacteriocin AS-48 cyclic peptide.

Langdon GM, Bruix M, Gálvez A, Valdivia E, Maqueda M, Rico M.

J Biomol NMR. 1998 Jul;12(1):173-5.

PMID:
9729795
39.

Cooperative stabilization of a molten globule apoflavodoxin fragment.

Maldonado S, Jiménez MA, Langdon GM, Sancho J.

Biochemistry. 1998 Jul 28;37(30):10589-96.

PMID:
9692948
40.
41.
42.

Constitutive calcium-dependent isoform of nitric oxide synthase in the human placental villous vascular tree.

Myatt L, Brockman DE, Langdon G, Pollock JS.

Placenta. 1993 Jul-Aug;14(4):373-83.

PMID:
7504255
43.

Attenuation of the vasoconstrictor effects of thromboxane and endothelin by nitric oxide in the human fetal-placental circulation.

Myatt L, Brewer AS, Langdon G, Brockman DE.

Am J Obstet Gynecol. 1992 Jan;166(1 Pt 1):224-30.

PMID:
1733199
44.

Endothelin-1-induced vasoconstriction is not mediated by thromboxane release and action in the human fetal-placental circulation.

Myatt L, Langdon G, Brewer AS, Brockman DE.

Am J Obstet Gynecol. 1991 Dec;165(6 Pt 1):1717-22.

PMID:
1750466
45.

The palpated (and observed), repeated, forced maximal expiration in physical diagnosis.

Brody AW, Martin JS, Kellog SG, Langdon GJ.

Am Rev Respir Dis. 1969 Dec;100(6):880-5. No abstract available.

PMID:
5357702
46.

The palpated (and observed) repeated, maximal expiration in physical diagnosis.

Brody AW, San Martin J, Kellogg SG, Langdon GJ.

Tuberculol Thorac Dis. 1966 Dec;23(4):84-90. No abstract available.

PMID:
5981172

Supplemental Content

Loading ...
Support Center